|
COPB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.938400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.001800E-02 |
| Normal-vs-Stage2 |
8.929900E-02 |
| Normal-vs-Stage3 |
3.141600E-03 |
| Normal-vs-Stage4 |
2.041900E-03 |
| Stage1-vs-Stage2 |
9.049000E-01 |
| Stage1-vs-Stage3 |
2.062600E-01 |
| Stage1-vs-Stage4 |
1.822980E-01 |
| Stage2-vs-Stage3 |
4.753000E-01 |
| Stage2-vs-Stage4 |
3.653600E-01 |
| Stage3-vs-Stage4 |
7.271000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.220300E-03 |
| Normal-vs-AfricanAmerican |
8.016400E-01 |
| Normal-vs-Asian |
1.715840E-02 |
| Caucasian-vs-AfricanAmerican |
1.132820E-01 |
| Caucasian-vs-Asian |
7.098800E-01 |
| AfricanAmerican-vs-Asian |
1.107360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.077400E-03 |
| Normal-vs-Female |
1.807900E-02 |
| Male-vs-Female |
2.831400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.249800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.638400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.918500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.314400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.109600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.639240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.821000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.858200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.318400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.718200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.367030E-01 |
| Classical-VS-Follicular |
4.079100E-03 |
| Classical-VS-Other |
5.037800E-02 |
| Classical-VS-Normal |
8.631600E-02 |
| Tall-VS-Follicular |
7.125600E-01 |
| Tall-VS-Other |
2.109000E-01 |
| Tall-VS-Normal |
9.675600E-03 |
| Follicular-VS-Other |
3.899200E-01 |
| Follicular-VS-Normal |
1.022550E-03 |
| Other-VS-Normal |
7.819500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.019900E-03 |
| Normal-vs-N1 |
1.696080E-03 |
| N0-vs-N1 |
4.084200E-01 |
|
|
